✦ LIBER ✦

Changes in immunological parameters after conversion from cyclosporine A to azathioprine in renal transplant recipients

✍ Scribed by D.J. Versluis; A.M. Bijma; L.M.B. Vaessen; W. Weimar

Publisher: Elsevier Science
Year: 1989
Tongue: English
Weight: 555 KB
Volume: 11
Category: Article
ISSN: 0192-0561
DOI: 10.1016/0192-0561(89)90067-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Conversion from liquid to solid rapamyci

Conversion from liquid to solid rapamycin formulations in stable renal allograft transplant recipients

✍ Patrick A. Kelly; Kimberly Napoli; Barry D. Kahan 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 122 KB

Sirolimus (rapamycin, RAPA, Rapamune™) is a potent immunosuppressive agent currently being investigated for prophylaxis against acute rejection episodes in renal transplant recipients. In the present study, stable renal allograft recipients under maintenance therapy with RAPA and cyclosporine (CsA)

Improvement of renal function after the

Improvement of renal function after the switch from a calcineurin inhibitor to everolimus in liver transplant recipients with chronic renal dysfunction

✍ Javier F. Castroagudín; Esther Molina; Rafael Romero; Esteban Otero; Santiago To 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 141 KB 👁 1 views

Chronic renal dysfunction is a frequent and severe complication in solid-organ transplant recipients. Calcineurin inhibitors (CNIs) are the main pathogenic factors of renal dysfunction. Switching from CNIs to nonnephrotoxic drugs, such as mammalian target of rapamycin inhibitors (everolimus and siro

A randomized controlled trial of late co

A randomized controlled trial of late conversion from calcineurin inhibitor (CNI)-based to sirolimus-based immunosuppression in liver transplant recipients with impaired renal function

✍ Christopher J.E. Watson; Alexander E.S. Gimson; Graeme J. Alexander; Michael E.D 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 307 KB 👁 1 views

Renal impairment is common in patients after liver transplantation and is attributable in large part to the use of calcineurin inhibitor (CNI)-based immunosuppression. We sought to determine whether conversion to sirolimus-based immunosuppression was associated with improved renal function. In a sin